English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Artesunate, a new antimalarial clinical drug, exhibits potent anti-AML activity by targeting the ROS/Bim and TFRC/Fe2+ pathways Journal article
Liu, Yi, Li, Han, Luo, Zhihong, Yu, You, Yang, Jingzhao, Zhang, Min, Law, Betty Yuen Kwan, Huang, Zan, Li, Wenhua. Artesunate, a new antimalarial clinical drug, exhibits potent anti-AML activity by targeting the ROS/Bim and TFRC/Fe2+ pathways[J]. British Journal of Pharmacology, 2022, 180(6), 701-720.
Authors:  Liu, Yi;  Li, Han;  Luo, Zhihong;  Yu, You;  Yang, Jingzhao; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:6.8/7.4 | Submit date：2023/01/30
Acute Myeloid Leukaemia  Apoptosis  Artesunate  Bim  Differentiation  Tfrc  
A multifunctional oxidative stress nanoamplifier with ROS amplification and GSH exhaustion for enhanced chemodynamic therapy Journal article
Zhong, Wenzhao, Guo, Feng, Chen, Fangman, Law, Man Kay, Lu, Jun, Shao, Dan, Yu, Hua, Chan, Ging, Chen, Meiwan. A multifunctional oxidative stress nanoamplifier with ROS amplification and GSH exhaustion for enhanced chemodynamic therapy[J]. Frontiers in Pharmacology, 2022, 13, 1044083.
Authors:  Zhong, Wenzhao;  Guo, Feng;  Chen, Fangman;  Law, Man Kay;  Lu, Jun; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:4.4/5.0 | Submit date：2023/01/31
Artesunate  Chemodynamic Therapy  Gsh Exhaustion  Intratumoral Catalytic Nanomaterials  Ros Amplification  
Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation Journal article
Cao, Dai, Chen, Die, Xia, Jiang Nan, Wang, Wen Yan, Zhu, Guo Yuan, Chen, Li Wen, Zhang, Chuantao, Tan, Bo, Li, Hui, Li, Ying Wei. Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation[J]. Biomedicine and Pharmacotherapy, 2022, 155.
Authors:  Cao, Dai;  Chen, Die;  Xia, Jiang Nan;  Wang, Wen Yan;  Zhu, Guo Yuan; et al.
Favorite | TC[WOS]:10 TC[Scopus]:10  IF:6.9/6.8 | Submit date：2023/01/31
Anti-tumor Immunity  Artesunate  Egfr-tki Resistance  Non-small-cell Lung Cancer  Pd-l1  Taz  
NIR-responsive polydopamine-based calcium carbonate hybrid nanoparticles delivering artesunate for cancer chemo-photothermal therapy Journal article
Zhong, Wenzhao, Wong, Ka Hong, Xu, Fujian, Zhao, Nana, Chen, Meiwan. NIR-responsive polydopamine-based calcium carbonate hybrid nanoparticles delivering artesunate for cancer chemo-photothermal therapy[J]. Acta Biomaterialia, 2022, 145, 135-145.
Authors:  Zhong, Wenzhao;  Wong, Ka Hong;  Xu, Fujian;  Zhao, Nana;  Chen, Meiwan
Favorite | TC[WOS]:24 TC[Scopus]:25  IF:9.4/9.9 | Submit date：2022/05/17
Polydopamine-based Calcium Carbonate Hybrid Nanoparticles  Artesunate  Cancer Chemo-photothermal Therapy  
Neurogenesis and Proliferation of Neural Stem/Progenitor Cells Conferred by Artesunate via FOXO3a/p27Kip1 Axis in Mouse Stroke Model Journal article
Zhang, Kaiyuan, Yang, Yang, Ge, Hongfei, Wang, Ju, Lei, Xuejiao, Chen, Xuezhu, Wan, Feng, Feng, Hua, Tan, Liang. Neurogenesis and Proliferation of Neural Stem/Progenitor Cells Conferred by Artesunate via FOXO3a/p27Kip1 Axis in Mouse Stroke Model[J]. Molecular Neurobiology, 2022, 59(8), 4718-4729.
Authors:  Zhang, Kaiyuan;  Yang, Yang;  Ge, Hongfei;  Wang, Ju;  Lei, Xuejiao; et al.
Favorite | TC[WOS]:39 TC[Scopus]:40  IF:4.6/4.7 | Submit date：2022/08/05
Artesunate  Foxo3a/p27kip1 Axis  Neural Stem/progenitor Cells  Stroke  White Matter Injury  
c-Myc-PD-L1 Axis Sustained Gemcitabine-Resistance in Pancreatic Cancer Journal article
Yao, Jingjing, Huang, Min, Shen, Qinghong, Ding, Ming, Yu, Shaofang, Guo, Yajuan, Lin, Yuefang, Zheng, Yaqiu, Chen, Wenbo, Yan, Wenxin, Liu, Zhongqiu, Wang, Dawei, Hu, Ming, Lu, Linlin. c-Myc-PD-L1 Axis Sustained Gemcitabine-Resistance in Pancreatic Cancer[J]. Frontiers in Pharmacology, 2022, 13.
Authors:  Yao, Jingjing;  Huang, Min;  Shen, Qinghong;  Ding, Ming;  Yu, Shaofang; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:4.4/5.0 | Submit date：2023/01/30
Artesunate  C-myc  Gemcitabine Resistance  Pancreatic Cancer  Pd-l1